Hedge Fund - Newtyn Management

Merrimack Pharmaceuticals Inc (MACK) 

Holding History Records
No. Filing Period Value % of Portfolio Number of Shares Avg. Quarterly Share Price
1 2023 - Q4 (2023-12-31) $25,126,237 4.93% 1,873,694 $12.64
2 2023 - Q3 (2023-09-30) $23,102,647 5.7% 1,873,694 $12.11
3 2023 - Q2 (2023-06-30) $23,046,436 5.44% 1,873,694 $12.50
4 2023 - Q1 (2023-03-31) $23,027,699 4.52% 1,873,694 $11.75
5 2022 - Q4 (2022-12-31) $20,265,795 4.18% 1,768,394 $8.24
6 2022 - Q3 (2022-09-30) $6,627,000 1.45% 1,767,094 $4.62
7 2022 - Q2 (2022-06-30) $10,460,000 1.98% 1,758,005 $5.64
8 2022 - Q1 (2022-03-31) $10,830,000 2.59% 1,713,612 $5.62
9 2021 - Q4 (2021-12-31) $6,056,000 1.6% 1,548,883 $4.34
10 2021 - Q3 (2021-09-30) $7,481,000 1.99% 1,548,883 $5.22
11 2021 - Q2 (2021-06-30) $9,866,000 2.73% 1,548,883 $6.60
12 2021 - Q1 (2021-03-31) $9,696,000 2.61% 1,548,883 $7.15
13 2020 - Q4 (2020-12-31) $10,672,000 2.45% 1,548,883 $4.93
14 2020 - Q3 (2020-09-30) $5,186,000 1.25% 1,296,436 $3.67
15 2020 - Q2 (2020-06-30) $3,995,000 1.46% 1,199,606 $3.41
16 2020 - Q1 (2020-03-31) $2,522,000 0.86% 1,173,166 $2.93
17 2019 - Q4 (2019-12-31) $3,695,000 0.34% 1,173,166 $4.00
18 2019 - Q3 (2019-09-30) $5,268,000 0.49% 1,173,166 $5.00
19 2019 - Q2 (2019-06-30) $7,333,000 0.94% 1,540,635.024 $4.74
20 2019 - Q1 (2019-03-31) $7,955,000 1.5% 1,454,764.993 $4.60
21 2018 - Q4 (2018-12-31) $3,430,000 0.67% 1,129,436.02 $3.47
22 2018 - Q3 (2018-09-30) $3,598,000 0.61% 857,925 $4.21
23 2018 - Q2 (2018-06-30) $3,109,000 0.58% 804,920.487 $6.64
24 2018 - Q1 (2018-03-31) $1,134,000 0.2% 179,029.247 $8.28
25 2017 - Q4 (2017-12-31) $3,714,000 0.56% 460,527.785 $9.32
26 2017 - Q3 (2017-09-30) $5,671,000 0.91% 495,690 $10.51

The displayed share prices are average quarterly stock market prices.

The share numbers are adjusted according to following stock splits:

  1. 1271.0000:1000.0000 on 2019-09-06

  2. 1.0000:10.0000 on 2017-09-06